SCHEMBL2370632

SCHEMBL2370632

O=C(O)c1cnc(NC(=O)c2ccccc2C(=O)O)s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.58
ALDH1A1 P00352 2/20 0.55
KDM4E B2RXH2 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
POLB P06746 2/20 0.55
LMNA P02545 1/20 0.55
MAPT P10636 1/20 0.55
PKM P14618 1/20 0.55
HPGD P15428 1/20 0.55
ALOX15 P16050 1/20 0.55
ALOX12 P18054 1/20 0.55
HSD17B10 Q99714 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
DDX3X O00571 4/20 0.52
KMT2A Q03164 3/20 0.51
MEN1 O00255 2/20 0.51
SCD O00767 1/20 0.49
KDR P35968 1/20 0.49
RAB9A P51151 2/20 0.48
STAT3 P40763 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4716373 0.87 MAPK14 (0.59) CYP1A2ALDH1A1KDM4EMAPTPKM
SCHEMBL2664534 0.84 KDR (0.68) CYP1A2ALDH1A1PKMKMT2AMEN1
SCHEMBL24073707 0.84 CYP1A2 (0.55) CYP1A2ALDH1A1KDM4EL3MBTL1POLB
SCHEMBL15283269 0.84 CYP1A2 (0.57) CYP1A2ALDH1A1KDM4EL3MBTL1POLB
SCHEMBL24074605 0.84 CYP1A2 (0.57) CYP1A2ALDH1A1KDM4EL3MBTL1POLB
SCHEMBL27135218 0.81 CYP1A2 (0.55) CYP1A2ALDH1A1KDM4EL3MBTL1POLB
SCHEMBL2370331 0.81 DDX3X (0.54) CYP1A2ALDH1A1KDM4EPOLBLMNA
SCHEMBL6177659 0.80 CDK2 (0.73) CYP1A2ALDH1A1KDM4EL3MBTL1POLB
SCHEMBL29056922 0.79 STAT3 (0.77) ALDH1A1POLBLMNAMAPTPKM
SCHEMBL25142632 0.76 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130281708-A1 Process for the Production of 2-Amino-5-Fluorothiazole TAKEDA CALIFORNIA, INC. (US) 2013-10-24 US disclosed
US-20130281708-A1 Process for the Production of 2-Amino-5-Fluorothiazole TAKEDA CALIFORNIA, INC. (US) 2013-10-24 US disclosed
EP-2547667-A1 PROCESS FOR THE PRODUCTION OF 2-AMINO-5-FLUOROTHIAZOLE Takeda California, Inc. (US) 2013-01-23 EP disclosed
WO-2011115758-A1 PROCESS FOR THE PRODUCTION OF 2-AMINO-5-FLUOROTHIAZOLE TAKEDA SAN DIEGO, INC. (US) 2011-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281708-A1 Process for the Production of 2-Amino-5-Fluorothiazole GFPT1, PFAS, PFKFB4 CYP1A2 1572/4885ALDH1A1 1653/4885KDM4E 1606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.